News

Mistral’s Le Chat adds deep research agent and voice mode to challenge OpenAI’s enterprise dominance
Mistral added deep research capabilities to its Le Chat platform, bringing it in direct competition against ChatGPT and ...
Asianet Newsable on MSN53m
GSK’s Blenrep Underwhelms FDA Panel Over Dose Risk-Benefit Balance In Myeloma; Retail Traders Stay Optimistic
The median progression-free survival was 32.6 months on the Blenrep combo compared to 12.5 months on the alternative. While ...